Evidence map›Paper›PMID 35971252›Full record

ArticleThe Journal of antimicrobial chemotherapy2022

Faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in the community in Switzerland.

Magdalena Nüesch-Inderbinen, Michael Biggel, Katrin Zurfluh, Andrea Treier, Roger Stephan

Open access · hybridAbstract read
In one paragraph

Article in The Journal of antimicrobial chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Cross-Sector Antimicrobial Resistance and Virulence inAntibiotics (Basel, Switzerland) · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Non-Clinical microbiology reviews · 2024
    Review
  7. High prevalence and plasmidome diversity ofFrontiers in microbiology · 2024
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Magdalena Nüesch-InderbinenInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, 272 Winterthurerstrasse, 8057 Zurich, Switzerland.ORCID 0000-0002-3242-9739
Michael BiggelInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, 272 Winterthurerstrasse, 8057 Zurich, Switzerland.ORCID 0000-0002-1337-2132
Katrin ZurfluhInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, 272 Winterthurerstrasse, 8057 Zurich, Switzerland.
Andrea TreierInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, 272 Winterthurerstrasse, 8057 Zurich, Switzerland.
Roger StephanInstitute for Food Safety and Hygiene, Vetsuisse Faculty, University of Zurich, 272 Winterthurerstrasse, 8057 Zurich, Switzerland.
University of Zurich · CH

Funding

Swiss Federal Office of Public Health, Division of Communicable Diseases
6 · The paper itself

Abstract

objectivesThis study aimed to investigate the faecal carriage of enterococci harbouring oxazolidinone resistance genes among healthy humans in Switzerland and to genetically characterize the isolates.

methodsA total of 399 stool samples from healthy individuals employed in different food-processing plants were cultured on a selective medium containing 10 mg/L florfenicol. Resulting enterococci were screened by PCR for the presence of cfr, optrA and poxtA. A hybrid approach combining short-read and long-read WGS was used to analyse the genetic context of the cfr, optrA and poxtA genes.

resultsEnterococcus faecalis (n = 6), Enterococcus faecium (n = 6), Enterococcus gallinarum (n = 1) and Enterococcus hirae (n = 2) were detected in 15/399 (3.8%) of the faecal samples. They carried cfr + poxtA, optrA, optrA + poxtA or poxtA. Four E. faecalis harbouring optrA and one E. faecium carrying poxtA were resistant to linezolid (8 mg/L). In most optrA-positive isolates, the genetic environments of optrA were highly variable, but often resembled previously described platforms. In most poxtA-positive isolates, the poxtA gene was flanked on both sides by IS1216E elements and located on medium-sized plasmids.

conclusionsFaecal carriage of Enterococcus spp. harbouring cfr, optrA and poxtA in healthy humans associated with the food-production industry demonstrates the possibility of spread of oxazolidinone resistance genes into the community. Given the importance of linezolid as a last-resort antibiotic for the treatment of serious infections caused by Gram-positive pathogens, the detection of the oxazolidinone resistance determinants in enterococci from healthy humans is of concern for public health.

Indexed as

Enterococcus faeciumGram-Positive Bacterial InfectionsOxazolidinonesAnti-Bacterial AgentsDrug Resistance, BacterialEnterococcusEnterococcus faecalisHumansLinezolidSwitzerlandAnti-Bacterial AgentsLinezolidOxazolidinones

Identifiers

PMID35971252
PMCPMC9525073
OpenAlexW4291916013

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.